Karin A. Kook

2.6k total citations · 1 hit paper
21 papers, 1.8k citations indexed

About

Karin A. Kook is a scholar working on Hematology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Karin A. Kook has authored 21 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 5 papers in Infectious Diseases and 5 papers in Molecular Biology. Recurrent topics in Karin A. Kook's work include Multiple Myeloma Research and Treatments (6 papers), Alzheimer's disease research and treatments (3 papers) and Neuroscience and Neuropharmacology Research (3 papers). Karin A. Kook is often cited by papers focused on Multiple Myeloma Research and Treatments (6 papers), Alzheimer's disease research and treatments (3 papers) and Neuroscience and Neuropharmacology Research (3 papers). Karin A. Kook collaborates with scholars based in United States, United Kingdom and Switzerland. Karin A. Kook's co-authors include Robert Terkeltaub, Daniel E. Furst, Matthew W. Davis, R. S. Crockett, Katherine Bennett, Steve D. Thomas, Peter Bentham, Claude M. Wischik, Steve K. Teo and Charles R. Harrington and has published in prestigious journals such as The Lancet, Blood and Brain Research.

In The Last Decade

Karin A. Kook

21 papers receiving 1.7k citations

Hit Papers

Efficacy and safety of tau-aggregation inhibitor therapy ... 2016 2026 2019 2022 2016 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial
    2016 321 citations Serge Gauthier, Howard Feldman et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karin A. Kook United States 18 516 485 370 310 284 21 1.8k
Johannes Stegbauer Germany 29 663 1.3× 313 0.6× 306 0.8× 339 1.1× 200 0.7× 97 2.4k
Magdalena Korecka United States 25 662 1.3× 899 1.9× 95 0.3× 263 0.8× 155 0.5× 49 2.7k
István Édes Hungary 37 1.2k 2.4× 765 1.6× 110 0.3× 902 2.9× 309 1.1× 191 6.5k
Katsuji Oguchi Japan 28 920 1.8× 399 0.8× 89 0.2× 194 0.6× 200 0.7× 175 2.4k
Marie‐Aude Devynck France 26 900 1.7× 624 1.3× 109 0.3× 275 0.9× 117 0.4× 86 2.2k
Susumu Sasaki Japan 28 383 0.7× 401 0.8× 260 0.7× 313 1.0× 85 0.3× 137 2.3k
Andreas Andersen Denmark 28 625 1.2× 467 1.0× 1.3k 3.5× 564 1.8× 376 1.3× 71 4.3k
Sidney S. Schreiber United States 29 860 1.7× 442 0.9× 118 0.3× 221 0.7× 141 0.5× 79 2.6k
Xuefeng Wang China 31 1.1k 2.2× 303 0.6× 75 0.2× 231 0.7× 166 0.6× 168 3.2k
A. Löwenthal Belgium 30 803 1.6× 338 0.7× 108 0.3× 211 0.7× 70 0.2× 147 2.7k

Countries citing papers authored by Karin A. Kook

Since Specialization
Citations

This map shows the geographic impact of Karin A. Kook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin A. Kook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin A. Kook more than expected).

Fields of papers citing papers by Karin A. Kook

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin A. Kook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin A. Kook. The network helps show where Karin A. Kook may publish in the future.

Co-authorship network of co-authors of Karin A. Kook

This figure shows the co-authorship network connecting the top 25 collaborators of Karin A. Kook. A scholar is included among the top collaborators of Karin A. Kook based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin A. Kook. Karin A. Kook is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ball, Brian, Anthony S. Stein, Gautam Borthakur, et al.. (2020). Trial in Progress: A Phase I Trial of BTX-A51 in Patients with Relapsed or Refractory AML or High-Risk MDS. Blood. 136(Supplement 1). 18–19. 5 indexed citations
3.
Schelter, B., Thomas C. Baddeley, Christopher M. Rubino, et al.. (2019). Concentration-Dependent Activity of Hydromethylthionine on Cognitive Decline and Brain Atrophy in Mild to Moderate Alzheimer’s Disease. Journal of Alzheimer s Disease. 72(3). 931–946. 33 indexed citations
4.
Gauthier, Serge, Howard Feldman, Lon S. Schneider, et al.. (2016). Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial. The Lancet. 388(10062). 2873–2884. 321 indexed citations breakdown →
5.
Wischik, Claude M., Roger T. Staff, Damon Wischik, et al.. (2015). Tau Aggregation Inhibitor Therapy: An Exploratory Phase 2 Study in Mild or Moderate Alzheimer's Disease. Journal of Alzheimer s Disease. 44(2). 705–720. 199 indexed citations
6.
7.
8.
Villahermosa, Laarni G., Tranquilino T. Fajardo, Rodolfo M. Abalos, et al.. (2005). A RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, CONTROLLED DOSE COMPARISON OF THALIDOMIDE FOR TREATMENT OF ERYTHEMA NODOSUM LEPROSUM. American Journal of Tropical Medicine and Hygiene. 72(5). 518–526. 35 indexed citations
9.
Teo, Steve K., Wayne A. Colburn, William Tracewell, et al.. (2004). Clinical Pharmacokinetics of Thalidomide. Clinical Pharmacokinetics. 43(5). 311–327. 108 indexed citations
10.
Kook, Karin A., Henry Gabelnick, & Gordon W. Duncan. (2002). Pharmacokinetics of levonorgestrel 0.75 mg tablets. Contraception. 66(1). 73–76. 43 indexed citations
11.
Teo, Steve K., et al.. (2002). Thalidomide in the treatment of leprosy. Microbes and Infection. 4(11). 1193–1202. 105 indexed citations
12.
Teo, Steve K., Karin A. Kook, William Tracewell, et al.. (2001). Thalidomide Dose Proportionality Assessment following Single Doses to Healthy Subjects. The Journal of Clinical Pharmacology. 41(6). 662–667. 25 indexed citations
13.
Kaplan, Gilla, Steve D. Thomas, Daniel S. Fierer, et al.. (2000). Thalidomide for the Treatment of AIDS-Associated Wasting. AIDS Research and Human Retroviruses. 16(14). 1345–1355. 67 indexed citations
14.
Teo, Steve K., Patrick J. Sabourin, Katherine O’Brien, Karin A. Kook, & Steve D. Thomas. (2000). Metabolism of thalidomide in human microsomes, cloned human cytochrome P-450 isozymes, and Hansen?s disease patients. Journal of Biochemical and Molecular Toxicology. 14(3). 140–147. 58 indexed citations
15.
Teo, Steve K., Karin A. Kook, William Tracewell, et al.. (2000). Effect of a high-fat meal on thalidomide pharmacokinetics and the relative bioavailability of oral formulations in healthy men and women. Biopharmaceutics & Drug Disposition. 21(1). 33–40. 23 indexed citations
16.
Noormohamed, Faruq H., M Youle, Christopher Higgs, et al.. (1999). Pharmacokinetics and Hemodynamic Effects of Single Oral Doses of Thalidomide in Asymptomatic Human Immunodeficiency Virus-Infected Subjects. AIDS Research and Human Retroviruses. 15(12). 1047–1052. 24 indexed citations
17.
Montpied, Pascale, Abraham Weizman, Ronit Weizman, et al.. (1993). Repeated swim-stress reduces GABAA receptor α subunit mRNAs in the mouse hippocampus. Molecular Brain Research. 18(3). 267–272. 44 indexed citations
18.
Weizman, Abraham, Ronit Weizman, Karin A. Kook, et al.. (1990). Adrenalectomy prevents the stress-induced decrease in in vitro [3H]Ro15-1788 binding to GABAA benzodiazepine receptors in the mouse. Brain Research. 519(1-2). 347–350. 31 indexed citations
19.
Weizman, R., et al.. (1989). Repeated swim stress alters brain benzodiazepine receptors measured in vivo.. Journal of Pharmacology and Experimental Therapeutics. 249(3). 701–707. 100 indexed citations
20.
Muir, Keith T., et al.. (1986). Analysis of amiodarone and desethylamiodarone in serum and tears by reversed-phase high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 374(2). 394–399. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Johannes Stegbauer Breakdown of academic impact, for papers by Magdalena Korecka Breakdown of academic impact, for papers by István Édes Breakdown of academic impact, for papers by Katsuji Oguchi Breakdown of academic impact, for papers by Marie‐Aude Devynck Breakdown of academic impact, for papers by Susumu Sasaki Breakdown of academic impact, for papers by Andreas Andersen Breakdown of academic impact, for papers by Sidney S. Schreiber Breakdown of academic impact, for papers by Xuefeng Wang Breakdown of academic impact, for papers by A. Löwenthal
Rankless by CCL
2026